A comparative study to determine the safety and efficacy of Autologous Human Platelet Lysate (HPL)in treatment of Lateral Epicondylitis (Tennis Elbow)
Phase 1
Completed
- Conditions
- Health Condition 1: null- Lateral Epicondylitis (Tennis Elbow)
- Registration Number
- CTRI/2012/04/002611
- Lead Sponsor
- KASIAK RESEARCH PRIVATE LIMITED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Subjects with clinical diagnosis of tennis elbow within the last 3 months
2.Subjects both male and female, aged 18-60 years (both inclusive)
3.Subjects who are willing to give informed consent and adhere to the study protocol
Exclusion Criteria
1.Subjects aged less than 18 and more than 60 years
2.Subjects with autoimmune diseases
3.Subjects with immuno-compromised system
4.Subjects on Anti-coagulant therapy or blood thinning medicines like Aspirin
5.Subjects taking concomitant therapy that might interfere with the study results in investigators opinion or who had concomitant other injury of the tennis elbow tendons.
6.Subjects who have received treatment with corticosteroid injections within the last 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method